COSCIENS Biopharma (CSCI) Operating Margin

Annual Operating Margin

-400.36%
-129.92%-48.04%

December 1, 2023


Summary


Performance

CSCI Operating Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCSCIprofitabilitymetrics:

Quarterly Operating Margin

-258.36%
-97.68%-60.79%

September 1, 2024


Summary


Performance

CSCI Quarterly Operating Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCSCIprofitabilitymetrics:

Operating Margin Formula

Operating Profit Margin =  Operating Profit
Revenue
✕ 100%

CSCI Operating Margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-48.0%-62.2%
3 y3 years-141.1%-62.2%
5 y5 years-1193.6%-62.2%

CSCI Operating Margin Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-142.9%at low-716.9%at low
5 y5-year-142.9%+77.7%-716.9%at low
alltimeall time-1193.6%+99.9%-101.2%+83.5%

COSCIENS Biopharma Operating Margin History

DateAnnualQuarterly
Sep 2024
-
-258.36%(+60.8%)
Jun 2024
-
-160.68%(+82.0%)
Mar 2024
-
-88.27%(-44.6%)
Dec 2023
-400.36%(+48.0%)
-159.25%(+179.8%)
Sep 2023
-
-56.92%(-28.9%)
Jun 2023
-
-80.03%(+462.4%)
Mar 2023
-
-14.23%(+49.0%)
Dec 2022
-270.44%(+64.1%)
-9.55%(-133.9%)
Sep 2022
-
28.17%(-29.7%)
Jun 2022
-
40.07%(-4.3%)
Mar 2022
-
41.88%(+53.3%)
Dec 2021
-164.85%(-0.7%)
27.32%(+59.5%)
Sep 2021
-
17.13%(-10.0%)
Jun 2021
-
19.03%(+25.0%)
Mar 2021
-
15.22%(-374.7%)
Dec 2020
-166.05%(-90.7%)
-5.54%(-150.8%)
Sep 2020
-
10.90%(-61.5%)
Jun 2020
-
28.28%(+26.4%)
Mar 2020
-
22.38%(+167.1%)
Dec 2019
-1793.99%(-5000.3%)
8.38%(-607.9%)
Sep 2019
-
-1.65%(-84.5%)
Jun 2019
-
-10.62%(+19.3%)
Mar 2019
-
-8.90%(-141.1%)
Dec 2018
36.61%(-101.5%)
21.64%(-3481.3%)
Sep 2018
-
-0.64%(-118.0%)
Jun 2018
-
3.55%(-6016.7%)
Mar 2018
-
-0.06%(-99.9%)
Dec 2017
-2499.89%(-22.7%)
-54.28%(-329.7%)
Sep 2017
-
23.63%(-26.9%)
Jun 2017
-
32.32%(+278.9%)
Mar 2017
-
8.53%(-59.5%)
Dec 2016
-3235.57%(-49.4%)
21.07%(-42.2%)
Sep 2016
-
36.44%(-37.1%)
Jun 2016
-
57.92%(+25.8%)
Mar 2016
-
46.03%(-19.7%)
Dec 2015
-6400.73%(-98.1%)
57.35%(+44.8%)
Sep 2015
-
39.60%(+9.8%)
Jun 2015
-
36.06%(-619.6%)
Mar 2015
-
-6.94%(-212.5%)
Dec 2014
-339.95 K%(>+9900.0%)
6.17%(-81.1%)
Sep 2014
-
32.64%(+0.8%)
Jun 2014
-
32.38%(+53.5%)
Mar 2014
-
21.09%(-3736.2%)
Dec 2013
-444.96%(-69.3%)
-0.58%(-104.8%)
Sep 2013
-
12.05%(-193.3%)
Jun 2013
-
-12.91%(-157.3%)
Mar 2013
-
22.53%(-220.4%)
Dec 2012
-1448.42%(+114.9%)
-18.71%(+176.4%)
Sep 2012
-
-6.77%(-27.4%)
Jun 2012
-
-9.32%(-357.5%)
Mar 2012
-
3.62%(-78.8%)
Dec 2011
-673.90%(+652.6%)
17.07%(-562.6%)
Sep 2011
-
-3.69%(-128.5%)
Jun 2011
-
12.94%(-50.3%)
Mar 2011
-
26.05%(+87.0%)
Dec 2010
-89.54%
13.93%(+59.4%)
DateAnnualQuarterly
Sep 2010
-
8.74%(-804.8%)
Jun 2010
-
-1.24%(-261.0%)
Mar 2010
-
0.77%(-100.9%)
Dec 2009
-37.89%(-76.6%)
-86.58%(-823.3%)
Sep 2009
-
11.97%(-38.4%)
Jun 2009
-
19.42%(+15.3%)
Mar 2009
-
16.84%(-300.5%)
Dec 2008
-162.13%(+96.3%)
-8.40%(-82.0%)
Sep 2008
-
-46.58%(+112.8%)
Jun 2008
-
-21.89%(-57.4%)
Mar 2008
-
-51.34%(+49.7%)
Dec 2007
-82.61%(+41.8%)
-34.29%(-42.7%)
Sep 2007
-
-59.88%(-8084.0%)
Jun 2007
-
0.75%(-92.7%)
Mar 2007
-
10.24%(-114.1%)
Dec 2006
-58.24%(+186.9%)
-72.76%(+9228.2%)
Sep 2006
-
-0.78%(-106.4%)
Jun 2006
-
12.12%(+474.4%)
Mar 2006
-
2.11%(-93.2%)
Dec 2005
-20.30%(+26.8%)
31.06%(-890.3%)
Sep 2005
-
-3.93%(-181.7%)
Jun 2005
-
4.81%(-110.8%)
Mar 2005
-
-44.56%(-22.0%)
Dec 2004
-16.01%(+87.5%)
-57.15%(-29.7%)
Sep 2004
-
-81.34%(+568.4%)
Jun 2004
-
-12.17%(+83.8%)
Mar 2004
-
-6.62%(-1479.2%)
Dec 2003
-8.54%(-58.0%)
0.48%(-101.8%)
Sep 2003
-
-26.86%(-397.1%)
Jun 2003
-
9.04%(-134.5%)
Mar 2003
-
-26.17%(-36.6%)
Dec 2002
-20.32%(-49.9%)
-41.31%(+44.1%)
Sep 2002
-
-28.66%(-201.2%)
Jun 2002
-
28.32%(-127.6%)
Mar 2002
-
-102.48%(+0.4%)
Dec 2001
-40.55%(-73.1%)
-102.09%(+490.1%)
Sep 2001
-
-17.30%(-81.0%)
Jun 2001
-
-91.15%(+57.7%)
Mar 2001
-
-57.79%(-96.0%)
Dec 2000
-150.69%(-8.3%)
-1435.75%(+6252.9%)
Sep 2000
-
-22.60%(-54.8%)
Jun 2000
-
-50.00%(-75.0%)
Mar 2000
-
-200.00%(-87.2%)
Dec 1999
-164.25%(+13.9%)
-1566.64%(+4600.4%)
Sep 1999
-
-33.33%(-83.3%)
Jun 1999
-
-200.00%(+100.0%)
Mar 1999
-
-100.00%(-100.5%)
Dec 1998
-144.19%(+476.8%)
21.42 K%(<-9900.0%)
Sep 1998
-
-200.00%(+300.0%)
Jun 1998
-
-50.00%(-83.3%)
Mar 1998
-
-300.00%(-11.1%)
Dec 1997
-25.00%(-75.9%)
-337.32%(+57.4%)
Sep 1997
-
-214.29%(-54.9%)
Jun 1997
-
-475.00%(+39.7%)
Mar 1997
-
-340.00%
Dec 1996
-103.70%
-

FAQ

  • What is COSCIENS Biopharma annual operating profit margin?
  • What is the all time high annual operating margin for COSCIENS Biopharma?
  • What is COSCIENS Biopharma annual operating margin year-on-year change?
  • What is COSCIENS Biopharma quarterly operating profit margin?
  • What is the all time high quarterly operating margin for COSCIENS Biopharma?
  • What is COSCIENS Biopharma quarterly operating margin year-on-year change?

What is COSCIENS Biopharma annual operating profit margin?

The current annual operating margin of CSCI is -400.36%

What is the all time high annual operating margin for COSCIENS Biopharma?

COSCIENS Biopharma all-time high annual operating profit margin is 36.61%

What is COSCIENS Biopharma annual operating margin year-on-year change?

Over the past year, CSCI annual operating profit margin has changed by -129.92% (-48.04%)

What is COSCIENS Biopharma quarterly operating profit margin?

The current quarterly operating margin of CSCI is -258.36%

What is the all time high quarterly operating margin for COSCIENS Biopharma?

COSCIENS Biopharma all-time high quarterly operating profit margin is 21.42 K%

What is COSCIENS Biopharma quarterly operating margin year-on-year change?

Over the past year, CSCI quarterly operating profit margin has changed by -99.11% (-62.24%)